Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial.
Ann Surg Oncol. 2023 Aug;30(8):5071-5080. doi: 10.1245/s10434-023-13383-w. Epub 2023 Apr 13.
Ann Surg Oncol. 2023.
PMID: 37052821
Clinical Trial.
Combination therapy for pancreatic cancer: anti-PD-(L)1-based strategy.
Liu L, Huang X, Shi F, Song J, Guo C, Yang J, Liang T, Bai X.
Liu L, et al.
J Exp Clin Cancer Res. 2022 Feb 9;41(1):56. doi: 10.1186/s13046-022-02273-w.
J Exp Clin Cancer Res. 2022.
PMID: 35139879
Free PMC article.
Review.
Item in Clipboard
Combinational blockade of MET and PD-L1 improves pancreatic cancer immunotherapeutic efficacy.
Li E, Huang X, Zhang G, Liang T.
Li E, et al.
J Exp Clin Cancer Res. 2021 Sep 3;40(1):279. doi: 10.1186/s13046-021-02055-w.
J Exp Clin Cancer Res. 2021.
PMID: 34479614
Free PMC article.
Item in Clipboard
[Effects of neoadjuvant therapy on postoperative complication of pancreatic cancer surgery].
Bai XL, Su W, Li X, Liang TB.
Bai XL, et al.
Zhonghua Wai Ke Za Zhi. 2018 Nov 1;56(11):805-808. doi: 10.3760/cma.j.issn.0529-5815.2018.11.002.
Zhonghua Wai Ke Za Zhi. 2018.
PMID: 30392298
Chinese.
Item in Clipboard
Cite
Cite